145 related articles for article (PubMed ID: 15384793)
1. Pathogenic significance of hypertrophic mesothelial cells in peritoneal effluent and ex vivo culture.
Bajo MA; del Peso G; Castro MA; Cirugeda A; Castro MJ; Olea T; Costero O; Sánchez-Tomero JA; Díaz C; Selgas R
Adv Perit Dial; 2004; 20():43-6. PubMed ID: 15384793
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters.
Díaz C; Selgas R; Castro MA; Bajo MA; Fernández de Castro M; Molina S; Jiménez C; Ortiz A; Vara F
Adv Perit Dial; 1998; 14():19-24. PubMed ID: 10649684
[TBL] [Abstract][Full Text] [Related]
4. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
[TBL] [Abstract][Full Text] [Related]
5. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
6. [Methods to assess the ex vivo growth capacity of mesothelial cells obtained directly from peritoneal effluent].
Castro MA; Díaz C; Bajo MA; Sánchez-Cabezudo MJ; Fernández de Castro M; del Peso G; Martínez ME; Selgas R
Nefrologia; 2000; 20(3):277-83. PubMed ID: 10917005
[TBL] [Abstract][Full Text] [Related]
7. The relationship between peritoneal leukocyte count, fluid cultures, and clinical results in peritonitis among peritoneal dialysis patients: is there a geographic or ethnic difference?
Ozturk S; Sar F; Altas K; Uzun S; Yazici H; Bozfakioglu S; Kazancioglu R
Adv Perit Dial; 2009; 25():32-40. PubMed ID: 19886314
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents.
Vargha R; Endemann M; Kratochwill K; Riesenhuber A; Wick N; Krachler AM; Malaga-Dieguez L; Aufricht C
Nephrol Dial Transplant; 2006 Oct; 21(10):2943-7. PubMed ID: 16861732
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.
Mactier RA
Adv Perit Dial; 2000; 16():223-8. PubMed ID: 11045299
[TBL] [Abstract][Full Text] [Related]
10. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
11. [Anatomic-functional correlation of the peritoneal membrane].
del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
13. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
Ekim M; Fitöz S; Yagmurlu A; Ensari A; Yüksel S; Acar B; Ozçakar ZB; Kendirli T; Bingöler B; Yalçinkaya F
Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
[TBL] [Abstract][Full Text] [Related]
14. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with tamoxifen in peritoneal fibrosing syndromes.
del Peso G; Bajo MA; Gil F; Aguilera A; Ros S; Costero O; Castro MJ; Selgas R
Adv Perit Dial; 2003; 19():32-5. PubMed ID: 14763031
[TBL] [Abstract][Full Text] [Related]
16. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
17. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms].
Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B
Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495
[TBL] [Abstract][Full Text] [Related]
18. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis.
Garosi G; Di Paolo N
Adv Perit Dial; 2000; 16():204-7. PubMed ID: 11045294
[TBL] [Abstract][Full Text] [Related]
20. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
